Stocklytics Platform
Asset logo for symbol AMED
Amedisys
AMED53
$91.88arrow_drop_down0.10%-$0.09
Asset logo for symbol AMED
AMED53

$91.88

arrow_drop_down0.10%

Income Statement (AMED)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT$21.21M$64.11M$52.28M$20.96M$59.40M
EBITDA$25.98M$70.47M$58.42M$25.10M$65.46M
gross Profit$250.10M$130.54M$117.66M$430.18M$244.60M
NET Income$41.46M$32.30M$14.40M$39.37M$25.96M
total Revenue$587.67M$591.18M$571.41M$570.78M$556.23M

Balance Sheet (AMED)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt$222.22M$317.28M$361.11M$341.35M$412.09M
stockholders Equity$1.14B$1.12B$1.08B$1.06B$1.03B
total Assets$2.13B$2.11B$2.08B$2.06B$2.02B
total Debt$467.67M$474.64M$481.81M$487.21M$490.20M
total Liabilities$938.67M$938.48M$947.21M$940.38M$933.89M

Cash Flow (AMED)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow-$15.08M-$14.22M-$10.31M-$13.64M-$6.25M
free Cash Flow$104.23M$50.73M-$9.43M$58.20M-$11.04M
investing Cash Flow-----
operating Cash Flow$105.62M$52.30M-$6.54M$60.31M-$9.84M

Amedisys (AMED) Financials

Amedisys Inc (AMED) is a leading provider of home health and hospice care services in the United States. The company's financial performance is reflected in its income statement, which shows its revenue, expenses, and net income. In the most recent financial period, Amedisys reported total revenue of $1.7 billion, representing a 6% increase compared to the previous year. The company's gross profit for the period was $682 million. Net income from stockholders was $67 million.
On the balance sheet, Amedisys has total assets of $2.3 billion, with total liabilities of $1.5 billion. The company's stockholders' equity is $755 million. The balance sheet also shows the company's cash equivalents, which stood at $132 million. Amedisys has a net debt of $29 million and total debt of $175 million. The company's cash flow statement provides insights into its operating, investing, and financing activities. Operating cash flow for the period was $147 million, while investing cash flow was -$103 million. Financing cash flow was $1 million, resulting in a free cash flow of $44 million.
add Amedisys  to watchlist

Keep an eye on Amedisys

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level